Top Markets
Coin of the day
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals, Inc.

EIGR
Classement en actions #36561
Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical company... Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and bringing to market targeted therapies for rare and ultra-rare diseases across the United States and internationally. Its primary investigational drug, Lonafarnib, an orally administered small molecule, is currently undergoing Phase III clinical trials for the treatment of hepatitis delta virus (HDV) infection. Other promising candidates in its portfolio include Lambda, which has completed Phase II clinical trials and is designed to target type III interferon receptors; Lonafarnib, also being evaluated for progeria and progeroid laminopathies; and Avexitide, an agent for congenital hyperinsulinism that has also successfully concluded Phase II studies for post-bariatric hypoglycemia. Established in 2008, Eiger BioPharmaceuticals, Inc. maintains its headquarters in Palo Alto, California.
Prix de l'action
$1.73
Dernière synchronisation: 2025-06-17
Capitalisation boursière
$2.55M
Changement (1 jour)
-0.29%
Changement (1 an)
0.00%
Pays
US
Échange Eiger BioPharmaceuticals, Inc. (EIGR)

Catégorie

Le prix EIGR avec la capitalisation boursière de B
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.
EIGR
$1.73
Capitalisation boursière de Eiger BioPharmaceuticals, Inc.(EIGR)
Capitalisation boursière: $2.55M
En August 2026, Eiger BioPharmaceuticals, Inc. a une capitalisation boursière de $2.55M. Cela fait de Eiger BioPharmaceuticals, Inc. la 36561st entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Eiger BioPharmaceuticals, Inc. du 2014 au 2026
EIGR par rapport au top 5 des plus populaires stocks
Prix pour EIGR L’actif B La capitalisation boursière de B Résultats
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.
$3,684,828 $2.55M
$5.452T +213,613,124.72%
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.
$3,034,731 $2.55M
$4.490T +175,926,341.05%
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.
$2,813,303 $2.55M
$4.162T +163,089,914.17%
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.
$2,484,780 $2.55M
$3.676T +144,045,097.36%
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.
$1,914,807 $2.55M
$2.833T +111,003,211.28%